Patents Assigned to Fulgent Therapeutics, Inc.
  • Nanoparticles containing a taxane and their use
    Patent number: 11801230
    Abstract: Symmetrically and asymmetrically branched homopolymers are modified at the surface level with functional groups that enable forming aggregates with a taxane, such as, paclitaxel and derivatives thereof, which are water insoluble or poorly water soluble. The aggregates are formed by interaction of a taxane and a homopolymer. Such aggregates improve drug solubility, stability, delivery and efficacy.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: October 31, 2023
    Assignees: ANP Technologies, Inc., Fulgent Therapeutics, Inc.
    Inventors: Ray Yin, Jing Pan, Yubei Zhang, Bingsen Zhou, Yun Yen